ADIENNE is an integrated biopharmaceutical group with its headquarters based in Lugano, Switzerland, and its Pharma & Biotech manufacturing facilities based in Caponago, Italy. With a portfolio of orphan-designated marketed medicinal product, clinical and preclinical product candidates focusing on critical conditions of high unmet medical needs, ADIENNE developed and is developing a range of product candidates for orphan diseases for which existing treatment options are limited, the patient population is small and the clinical need for therapies is high. ADIENNE is the only pharmaceutical company in the world lyophilizing cytotoxic pharmaceutical products in ready-to-use systems such as Ready-To-Infuse Multichamber Flexible Bag. ADIENNE is the unique owner of the worldwide patents referred to these Ready-To-Infuse system technology.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
